Registration strategy for Kazakhstan
Support throughout expert assessment
Foreign manufacturer documentation review
Regulatory support for the registration of medicines and access to the pharmaceutical market of Kazakhstan

Drug Registration in Kazakhstan

State registration of medicines in Kazakhstan

To place a medicinal product on the Kazakhstan market, manufacturers must identify the applicable registration procedure and demonstrate compliance with the relevant requirements.

State registration is carried out by the competent authority responsible for medicines and medical devices. Expert assessment of the medicinal product is a mandatory part of the registration process.

Preparation starts well before submission. It includes establishing the product’s regulatory status, reviewing documentation, assessing dossier readiness and selecting a suitable registration strategy.

An initial review is particularly important for foreign manufacturers whose documentation was originally prepared for other markets.

Drug registration procedure in Kazakhstan

The sequence depends on the medicinal product and the applicable procedure. Preparation generally involves the following stages.

First, assess the product and available documentation. Review its registration history, manufacturer and manufacturing sites, and the readiness of the dossier.

Next, identify the required materials and assemble the registration dossier using the manufacturer’s source documentation.

Submit the documents under the applicable procedure and support the required expert assessment.

During review, the expert organisation may request additional documents, explanations or corrections to individual dossier sections.

Following successful completion of the required procedures, the competent authority decides on state registration of the medicinal product.

Expert assessment of medicines in Kazakhstan

Expert assessment is a mandatory condition for state registration of medicines in Kazakhstan under the Code on Public Health and the Healthcare System.

The assessment uses the submitted registration documentation to evaluate the medicinal product against the applicable requirements.

The quality of preparation matters: inconsistent information across dossier sections, insufficient evidence or outdated documents can lead to additional questions.

A regulatory dossier audit before submission helps identify gaps and resolve inconsistencies before the official procedure starts.

Requirements for foreign pharmaceutical manufacturers

Foreign manufacturers need to adapt their registration project to the requirements applicable in Kazakhstan.

Registration in the country of origin or another foreign market does not itself replace the registration procedure required for Kazakhstan.

Before starting, review:
• the product’s current registration status;
• manufacturer and manufacturing site details;
• available licences and authorisations;
• manufacturing and quality documentation;
• Good Manufacturing Practice (GMP) documentation;
• the registration dossier;
• medicinal product information;
• labelling and packaging;
• the product’s registration history.

The review establishes which documents can be used and which materials need to be prepared or updated.

Labelling and medicinal product information

Product information must comply with the applicable requirements before the medicine is placed on the market.

Draft labelling, packaging and medicinal product information are reviewed during registration preparation.

The name, strength, dosage form, composition, manufacturer, storage conditions, shelf life and other characteristics must be consistent with the registration documentation.

Consistency across documents is essential. Differences in manufacturer names, manufacturing site addresses, composition or other product characteristics may lead to questions during expert assessment.

Registration in Kazakhstan and EAEU rules

Kazakhstan is a member of the Eurasian Economic Union (EAEU). The registration strategy must therefore take account of the applicable EAEU framework for medicines.

EEC Council Decision No. 78 establishes the Rules for Registration and Expert Assessment of Medicinal Products for Human Use. The rules cover registration, confirmation of registration, dossier variations and related procedures within the common EAEU medicines market.

Kazakhstan’s national regulatory acts also govern relevant administrative procedures and refer to the EAEU rules.

The appropriate strategy must be assessed for each product before the project begins.

Further information on mutual recognition, reference states and recognition states is available on our EAEU drug registration page (Russian).

Documents for drug registration in Kazakhstan

Registration requires a dossier and the supporting materials specified by the applicable requirements. Kazakhstan’s Public Health Code provides for submission of the registration dossier to the expert organisation.

The document checklist depends on the medicinal product and the selected procedure.

Our Drug Registration Documents page (Russian) explains the CTD structure and the documents organised by module.

MedReg Eurasia can review the manufacturer’s available documentation and identify missing materials before the project starts.

Drug registration support in Kazakhstan

MedReg Eurasia provides regulatory support to manufacturers and pharmaceutical companies planning to register medicines in Kazakhstan.

Support may include an initial product assessment, review of registration status, dossier audit, verification of manufacturer and site documentation, dossier assembly, coordination throughout expert assessment and preparation of responses using manufacturer-provided information.

The scope is defined after reviewing the product and available documentation.

Planning to register a medicine in Kazakhstan?

Send the product details, manufacturer and site information, and available registration dossier.

We will assess readiness, clarify the applicable steps and identify the documents needed to prepare for registration.

Часто задаваемые вопросы о регистрации
лекарственных средств в Казахстане

Drug registration in Kazakhstan: FAQ

Can an overseas dossier be used for registration in Kazakhstan?

Manufacturer documentation can be used after its structure, contents and compliance with the applicable requirements have been assessed. A dossier audit identifies materials that need adaptation, updating or additional evidence.

Is expert assessment mandatory for medicines in Kazakhstan?

Yes. Expert assessment is a mandatory condition for state registration of a medicinal product under Kazakhstan’s applicable legislation.

Are GMP documents required for drug registration?

Manufacturing site and Good Manufacturing Practice requirements must be assessed for the medicinal product, manufacturer and applicable registration procedure.

What should I provide for an initial project assessment?

Provide the product name and composition, dosage form and strength, manufacturer and manufacturing site details, countries of current registration, GMP information and the available registration dossier.

How does registration in Kazakhstan relate to EAEU rules?

The applicable procedure and strategy depend on current requirements and the intended markets. EAEU projects must take account of the Rules for Registration and Expert Assessment of Medicinal Products approved by EEC Council Decision No. 78.

Can the dossier be reviewed before submission?

Yes. A pre-submission regulatory audit checks completeness and consistency and identifies issues that need to be resolved or addressed before the official procedure starts.

Discuss your drug registration project

Send the product description, manufacturer details and available dossier. We will clarify the registration route and the scope of regulatory support.

up_profit@mail.ru
+7 747 842 39 68

UP PROFIT LLP — holder of the MedReg Eurasia trademark.
270 Abish Kekilbayuly Street, Block 3, Almaty, Kazakhstan.
Monday–Saturday, 09:00–18:00. Sunday: closed.

Russian version · Privacy Policy (Russian)

Regulatory consulting and project support. The competent authority determines the registration outcome.

Contact us
Telegram
Mail
Phone
WhatsApp
website icon
WeChat
website icon
Linkedin
Made on
Tilda